Know Labs (NYSEAMERICAN:KNW) Shares Down 11.1%

Know Labs, Inc. (NYSEAMERICAN:KNWGet Free Report)’s stock price fell 11.1% during trading on Thursday . The company traded as low as $0.66 and last traded at $0.68. 195,689 shares traded hands during trading, an increase of 20% from the average session volume of 163,694 shares. The stock had previously closed at $0.76.

Know Labs Price Performance

The firm has a market capitalization of $55.06 million, a P/E ratio of -1.83 and a beta of 1.64.

Know Labs (NYSEAMERICAN:KNWGet Free Report) last announced its quarterly earnings results on Wednesday, February 14th. The company reported ($0.04) earnings per share for the quarter. On average, sell-side analysts predict that Know Labs, Inc. will post -0.07 earnings per share for the current year.

Institutional Trading of Know Labs

Several large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC increased its position in shares of Know Labs by 957.6% during the 2nd quarter. Geode Capital Management LLC now owns 154,033 shares of the company’s stock valued at $156,000 after purchasing an additional 139,469 shares during the period. Walleye Capital LLC acquired a new position in shares of Know Labs during the 3rd quarter valued at $180,000. Vanguard Group Inc. increased its position in shares of Know Labs by 112.3% during the 3rd quarter. Vanguard Group Inc. now owns 481,983 shares of the company’s stock valued at $120,000 after purchasing an additional 254,972 shares during the period. Callan Capital LLC increased its position in shares of Know Labs by 117.6% during the 4th quarter. Callan Capital LLC now owns 370,000 shares of the company’s stock valued at $188,000 after purchasing an additional 200,000 shares during the period. Finally, Northern Trust Corp increased its position in shares of Know Labs by 27.7% during the 4th quarter. Northern Trust Corp now owns 100,710 shares of the company’s stock valued at $51,000 after purchasing an additional 21,823 shares during the period. 3.23% of the stock is currently owned by institutional investors and hedge funds.

About Know Labs

(Get Free Report)

Know Labs, Inc, together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.

Further Reading

Receive News & Ratings for Know Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Know Labs and related companies with MarketBeat.com's FREE daily email newsletter.